135 related articles for article (PubMed ID: 29392553)
1. CD27
Zhu G; Liu Y; Zhang W; Huang Y; Li K
Immunol Res; 2018 Apr; 66(2):281-287. PubMed ID: 29392553
[TBL] [Abstract][Full Text] [Related]
2. Colorectal tumors are enriched with regulatory plasmablasts with capacity in suppressing T cell inflammation.
Mao H; Pan F; Wu Z; Wang Z; Zhou Y; Zhang P; Gou M; Dai G
Int Immunopharmacol; 2017 Aug; 49():95-101. PubMed ID: 28558303
[TBL] [Abstract][Full Text] [Related]
3. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.
Kristensen B
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836805
[TBL] [Abstract][Full Text] [Related]
4. TGF-β
Rathod SB; Tripathy AS
Hum Immunol; 2016 Dec; 77(12):1254-1263. PubMed ID: 27720959
[TBL] [Abstract][Full Text] [Related]
5. Tim-1 blockade with RMT1-10 increases T regulatory cells and prolongs the survival of high-risk corneal allografts in mice.
Tan X; Jie Y; Zhang Y; Qin Y; Xu Q; Pan Z
Exp Eye Res; 2014 May; 122():86-93. PubMed ID: 24613782
[TBL] [Abstract][Full Text] [Related]
6. T follicular regulatory cells infiltrate the human airways during the onset of acute respiratory distress syndrome and regulate the development of B regulatory cells.
Li H; Zhou R; Wang C; Li Y; Zheng G; Jiang S; Dong T; Bai J; Xu S
Immunol Res; 2018 Aug; 66(4):548-554. PubMed ID: 30051220
[TBL] [Abstract][Full Text] [Related]
7. CD21
Zhu S; Wang X; Wang J; Lin J; Cong Y; Qiao G
Exp Cell Res; 2017 Dec; 361(1):149-154. PubMed ID: 29054490
[TBL] [Abstract][Full Text] [Related]
8. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
[TBL] [Abstract][Full Text] [Related]
9. Tim-1
Gu XL; He H; Lin L; Luo GX; Wen YF; Xiang DC; Qiu J
APMIS; 2017 Oct; 125(10):872-879. PubMed ID: 28736945
[TBL] [Abstract][Full Text] [Related]
10. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
[TBL] [Abstract][Full Text] [Related]
11. Tim3
Sun H; Gao W; Pan W; Zhang Q; Wang G; Feng D; Geng X; Yan X; Li S
Inflammation; 2017 Aug; 40(4):1342-1350. PubMed ID: 28478516
[TBL] [Abstract][Full Text] [Related]
12. Dysfunction of regulatory T cells in patients with ankylosing spondylitis is associated with a loss of Tim-3.
Wang M; Liu C; Bond A; Yang J; Zhou X; Wang J; Ji B
Int Immunopharmacol; 2018 Jun; 59():53-60. PubMed ID: 29625390
[TBL] [Abstract][Full Text] [Related]
13. Patients with intracranial aneurysms presented defects in regulatory T cells, which were associated with impairment in Tim-3 upregulation.
Zhang HF; Liang GB; Zhao MG; Zhao GF; Luo YH
Int Immunopharmacol; 2018 Nov; 64():350-355. PubMed ID: 30243071
[TBL] [Abstract][Full Text] [Related]
14. Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells.
Gautron AS; Dominguez-Villar M; de Marcken M; Hafler DA
Eur J Immunol; 2014 Sep; 44(9):2703-2711. PubMed ID: 24838857
[TBL] [Abstract][Full Text] [Related]
15. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of CD8
Li GG; Cao YH; Run Y; Xu RX; Zheng ZD
Clin Exp Pharmacol Physiol; 2016 Dec; 43(12):1191-1198. PubMed ID: 27558304
[TBL] [Abstract][Full Text] [Related]
17. TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients.
Aravena O; Ferrier A; Menon M; Mauri C; Aguillón JC; Soto L; Catalán D
Arthritis Res Ther; 2017 Jan; 19(1):8. PubMed ID: 28103916
[TBL] [Abstract][Full Text] [Related]
18. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
Dutzan N; Gamonal J; Silva A; Sanz M; Vernal R
J Clin Periodontol; 2009 May; 36(5):396-403. PubMed ID: 19419438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
